b.kimani
Submits third-party assay reports on material purchased directly. Based in Bologna.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
99.53%
n=8
Suppliers covered
8
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041914 | Ipamorelin | SinoPep | SNP-2606-L4478 | Janoshik | 2026-Q3 | 99.14 | 5.49 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043636 | CJC-1295 (no DAC) | PPG | PPG-2512-D7211 | Janoshik | 2026-Q2 | 99.64 | 5.31 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042147 | SS-31 (Elamipretide) | JEEP | JEEP-2511-B8241 | Medutest | 2025-Q4 | 99.69 | 5.06 | 107.4 | Buyer-sourced | 0 | PASS |
| AX-2025-020010 | N-Acetyl Semax Amide | SWB | SWB-2504-W7050 | Janoshik | 2025-Q2 | 99.43 | 9.35 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018887 | CJC-1295 (no DAC) | TFS | TFS-{CAT}-9097 | Janoshik | 2025-Q2 | 98.75 | 3.51 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020987 | ARA-290 | WXT | WXT-2502-N3730 | PeptideMeter | 2025-Q2 | 98.74 | 4.21 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-018659 | Enclomiphene citrate | QSC | QSC-2501-L5841 | Janoshik | 2025-Q2 | 99.78 | 5.88 | — | Buyer-sourced | 0 | FAIL |
| AX-2024-004423 | Semax | GSP | GSP-2404-P2784 | Medutest | 2024-Q3 | 99.85 | 8.20 | 104.6 | Buyer-sourced | 0 | PASS |